4.3 Article

Absolute Quantification of E1, Ubiquitin-Like Proteins and Nedd8-MLN4924 Adduct by Mass Spectrometry

期刊

CELL BIOCHEMISTRY AND BIOPHYSICS
卷 67, 期 1, 页码 139-147

出版社

HUMANA PRESS INC
DOI: 10.1007/s12013-013-9625-5

关键词

Absolute quantification; Mass spectrometry; Ubiquitin (Ub); Ubiquitin-like proteins (Ubl); Ubiquitin activating enzymes (E1); MLN4924

向作者/读者索取更多资源

Ubiquitin (Ub) and ubiquitin-like (Ubl) proteins regulate a variety of important cellular processes by forming covalent conjugates with target proteins or lipids. Ubl conjugation is catalyzed by a cascade of proteins including activating enzymes (E1), conjugating enzymes (E2), and in many cases ligation enzymes (E3). The discovery of MLN4924 (Brownell et al., Mol Cell 37: 102-111, 1), an investigational small molecule that is a mechanism-based inhibitor of NEDD8-activating enzyme (NAE), reveals a promising strategy of targeting E1/Ubl pathway for therapeutic purposes. In order to better understand, the biochemical dynamics of Ubl conjugation in cells and tissues, we have developed a mass spectrometry-based method to quantify E1 and Ubls using isotope-labeled proteins as internal standards. Furthermore, we have used the described method to quantify levels of the covalent Nedd8-inhibitor adduct formed in MLN4924 treated cells and tissues. The Nedd8-MLN4924 adduct is a tight-binding inhibitor of NAE, and its cellular concentration represents an indirect pharmacodynamic readout of NAE/Nedd8 pathway inhibition.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Cleavage Specificity of Mycobacterium tuberculosis ClpP1P2 Protease and Identification of Novel Peptide Substrates and Boronate Inhibitors with Anti-bacterial Activity

Tatos Akopian, Olga Kandror, Christopher Tsu, Jack H. Lai, Wengen Wu, Yuxin Liu, Peng Zhao, Annie Park, Lisa Wolf, Lawrence R. Dick, Eric J. Rubin, William Bachovchin, Alfred L. Goldberg

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Toxicology

Proteasome inhibitors bortezomib and carfilzomib used for the treatment of multiple myeloma do not inhibit the serine protease HtrA2/Omi

Vilmos Csizmadia, Paul Hales, Christopher Tsu, Jingya Ma, Jiejin Chen, Pooja Shah, Paul Fleming, Joseph J. Senn, Vivek J. Kadambi, Larry Dick, Francis S. Wolenski

TOXICOLOGY RESEARCH (2016)

Article Biochemistry & Molecular Biology

Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor

Xingyue He, Jessica Riceberg, Teresa Soucy, Erik Koenig, James Minissale, Melissa Gallery, Hugues Bernard, Xiaofeng Yang, Hua Liao, Claudia Rabino, Pooja Shah, Kristina Xega, Zhong-hua Yan, Mike Sintchak, John Bradley, He Xu, Matt Duffey, Dylan England, Hirotake Mizutani, Zhigen Hu, Jianping Guo, Ryan Chau, Lawrence R. Dick, James E. Brownell, John Newcomb, Steve Langston, Eric S. Lightcap, Neil Bence, Sai M. Pulukuri

NATURE CHEMICAL BIOLOGY (2017)

Article Biochemistry & Molecular Biology

A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment

Marc L. Hyer, Michael A. Milhollen, Jeff Ciavarri, Paul Fleming, Tary Traore, Darshan Sappal, Jessica Huck, Judy Shi, James Gavin, Jim Brownell, Yu Yang, Bradley Stringer, Robert Griffin, Frank Bruzzese, Teresa Soucy, Jennifer Duffy, Claudia Rabino, Jessica Riceberg, Kara Hoar, Anya Lublinsky, Saurabh Menon, Michael Sintchak, Nancy Bump, Sai M. Pulukuri, Steve Langston, Stephen Tirrell, Mike Kuranda, Petter Veiby, John Newcomb, Ping Li, Jing Tao Wu, Josh Powe, Lawrence R. Dick, Paul Greenspan, Katherine Galvin, Mark Manfredi, Chris Claiborne, Benjamin S. Amidon, Neil F. Bence

NATURE MEDICINE (2018)

Article Biochemistry & Molecular Biology

Autoubiquitination of the 26S Proteasome on Rpn13 Regulates Breakdown of Ubiquitin Conjugates

Henrike C. Besche, Zhe Sha, Nikolay V. Kukushkin, Andreas Peth, Eva-Maria Hock, Woong Kim, Steven Gygi, Juan A. Gutierrez, Hua Liao, Lawrence Dick, Alfred L. Goldberg

EMBO JOURNAL (2014)

Article Biochemistry & Molecular Biology

Mechanistic Study of Uba5 Enzyme and the Ufm1 Conjugation Pathway

James M. Gavin, Kara Hoar, Qing Xu, Jingya Ma, Yafang Lin, Jiejin Chen, Wei Chen, Frank J. Bruzzese, Sean Harrison, William D. Mallender, Nancy J. Bump, Michael D. Sintchak, Neil F. Bence, Ping Li, Lawrence R. Dick, Alexandra E. Gould, Jesse J. Chen

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Chemistry, Multidisciplinary

Identification of Potent and Selective Non-covalent Inhibitors of the Plasmodium falciparum Proteasome

Hao Li, Christopher Tsu, Christopher Blackburn, Gang Li, Paul Hales, Lawrence Dick, Matthew Bogyo

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)

Article Multidisciplinary Sciences

Characterization of the Loss of SUMO Pathway Function on Cancer Cells and Tumor Proliferation

Xingyue He, Jessica Riceberg, Sai M. Pulukuri, Steve Grossman, Vaishali Shinde, Pooja Shah, James E. Brownell, Larry Dick, John Newcomb, Neil Bence

PLOS ONE (2015)

Article Multidisciplinary Sciences

Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome

Jessica L. Bridgford, Stanley C. Xie, Simon A. Cobbold, Charisse Flerida A. Pasaje, Susann Herrmann, Tuo Yang, David L. Gillett, Lawrence R. Dick, Stuart A. Ralph, Con Dogovski, Natalie J. Spillman, Leann Tilley

NATURE COMMUNICATIONS (2018)

Article Chemistry, Medicinal

Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum Proteasome

Stanley C. Xie, David L. Gillett, Natalie J. Spillman, Christopher Tsu, Madeline R. Luth, Sabine Ottilie, Sandra Duffy, Alexandra E. Gould, Paul Hales, Benjamin A. Seager, Carlie L. Charron, Frank Bruzzese, Xiaofeng Yang, Xiansi Zhao, Shih-Chung Huang, Craig A. Hutton, Jeremy N. Burrows, Elizabeth A. Winzeler, Vicky M. Avery, Lawrence R. Dick, Leann Tilley

JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Microbiology

The structure of the PA28-20S proteasome complex from Plasmodium falciparum and implications for proteostasis

Stanley C. Xie, Riley D. Metcalfe, Eric Hanssen, Tuo Yang, David L. Gillett, Andrew P. Leis, Craig J. Morton, Michael J. Kuiper, Michael W. Parker, Natalie J. Spillman, Wilson Wong, Christopher Tsu, Lawrence R. Dick, Michael D. W. Griffin, Leann Tilley

NATURE MICROBIOLOGY (2019)

Review Pharmacology & Pharmacy

The proteasome as a target for protozoan parasites

Stanley C. Xie, Lawrence R. Dick, Alexandra Gould, Stephen Brand, Leann Tilley

EXPERT OPINION ON THERAPEUTIC TARGETS (2019)

Article Multidisciplinary Sciences

Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma

Fazal Shirazi, Richard J. Jones, Ram K. Singh, Jianxuan Zou, Isere Kuiatse, Zuzana Berkova, Hua Wang, Hans C. Lee, Samuel Hong, Larry Dick, Nibedita Chattopadhyay, Robert Z. Orlowski

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Design of proteasome inhibitors with oral efficacy in vivo against Plasmodium falciparum and selectivity over the human proteasome

Stanley C. Xie, Riley D. Metcalfe, Hirotake Mizutani, Tanya Puhalovich, Eric Hanssen, Craig J. Morton, Yawei Du, Con Dogovski, Shih-Chung Huang, Jeffrey Ciavarri, Paul Hales, Robert J. Griffin, Lawrence H. Cohen, Bei-Ching Chuang, Sergio Wittlin, Ioanna Deni, Tomas Yeo, Kurt E. Ward, Daniel C. Barry, Boyin Liu, David L. Gillett, Benigno F. Crespo-Fernandez, Sabine Ottilie, Nimisha Mittal, Alisje Churchyard, Daniel Ferguson, Anna Caroline C. Aguiar, Rafael V. C. Guido, Jake Baum, Kirsten K. Hanson, Elizabeth A. Winzeler, Francisco-Javier Gamo, David A. Fidock, Delphine Baud, Michael W. Parker, Stephen Brand, Lawrence R. Dick, Michael D. W. Griffin, Alexandra E. Gould, Leann Tilley

Summary: The study identifies the Plasmodium falciparum proteasome as a potential antimalarial drug target and develops a series of potent inhibitors with high efficacy against malaria parasites and low likelihood of resistance. These findings offer insights for designing potent and selective antimalarial proteasome inhibitors.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Multidisciplinary Sciences

Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy

Stanley C. Xie, Riley D. Metcalfe, Elyse Dunn, Craig J. Morton, Shih-Chung Huang, Tanya Puhalovich, Yawei Du, Sergio Wittlin, Shuai Nie, Madeline R. Luth, Liting Ma, Mi-Sook Kim, Charisse Flerida A. Pasaje, Krittikorn Kumpornsin, Carlo Giannangelo, Fiona J. Houghton, Alisje Churchyard, Mufuliat T. Famodimu, Daniel C. Barry, David L. Gillett, Sumanta Dey, Clara C. Kosasih, William Newman, Jacquin C. Niles, Marcus C. S. Lee, Jake Baum, Sabine Ottilie, Elizabeth A. Winzeler, Darren J. Creek, Nicholas Williamson, Michael W. Parker, Stephen Brand, Steven P. Langston, Lawrence R. Dick, Michael D. W. Griffin, Alexandra E. Gould, Leann Tilley

Summary: This study identifies aminoacyl transfer RNA synthetases as potential drug targets and presents a novel compound that can inhibit these enzymes, effectively killing the malaria parasite.

SCIENCE (2022)

暂无数据